Overview

In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Subjects will receive the "Basel phenotyping cocktail" capsule orally with 120-200ml tap water in fasted state. After intake peripheral venous blood samples will be drawn. 12 patients (male and female) with liver cirrhosis for each Child Pugh Category A, B, and C, and 12 age- and gender-matched healthy control subjects will be included (in total 48 participants).
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Basel, Switzerland